Date of Report: October 2, 2024
Broker: CGS International
Company Overview
Karex Berhad is the world’s largest condom manufacturer, based in Malaysia. The company produces a wide range of sexual wellness products, including condoms, lubricants, and medical devices. Karex exports its products to over 140 countries and operates several manufacturing facilities in Malaysia and Thailand.
Technical Analysis
As of October 2, 2024, Karex’s stock is trading at RM0.840, down slightly from the entry price of RM0.865. Despite the minor decline, the stock remains part of the actively managed portfolio, as it continues to show long-term potential based on market trends and product demand.
Stock Position
- Entry Price: RM0.865
- Current Price: RM0.840
- Stop Loss: RM0.775
- Target Price: RM0.895, RM0.96
Investment Strategy
Karex holds 8% of the actively managed portfolio, with 115,600 shares. The stock is still marked as a “Buy,” with investors advised to maintain their positions, despite the slight decline. The stop-loss level is set at RM0.775, providing a risk management strategy while the stock moves toward its target price.
Performance Overview
As of the report date, Karex has recorded a slight loss of 2.9%, equivalent to RM2,890. However, the stock remains within acceptable risk parameters, and its long-term prospects are favorable, given the company’s global reach and leadership in the sexual wellness industry.
Conclusion
Karex remains a promising investment in the portfolio, with a stable outlook and potential for future gains. Despite a minor price decline, the stock’s fundamentals are strong, and it is expected to reach its target prices in the medium term. Investors are advised to stay invested, with the stop-loss level in place for risk management.
